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By their very nature, intrinsic cellular pathways form complex biological systems yet in many ways can open the door for the generation 
and development of novel therapeutic strategies for many disorders. Interestingly, it is the knowledge gained from examination of these 
pathways that provide the necessary insight and caution for the application of treatments for different disorders. For example, if one 
considers the vitamin B3 (niacin) and its amide form nicotinamide, this agent may be seen initially as a necessary nutrient and therapy 
that is vital for cellular function and deficiency states. Lack of nicotinamide can result in fatigue, loss of appetite, pigmented rashes of 
the skin and oral ulcerations. More severe states of deficiency lead to pellagra that is characterized by cutaneous rashes, oral ulcerations, 
gastrointestinal difficulties and cognitive loss. Pellagra can occur during conditions of low nicotinamide or the inability to absorb nico-
tinamide in the gastrointestinal tract. In addition, excessive alcohol consumption that is associated with poor dietary intake also can 
lead to severe nicotinamide loss and insufficient absorption. Supplementation with vitamin B3 that can generate nicotinamide through 
the conversion of nicotinic acid in the liver or through the hydrolysis of NAD+ can resolve these disorders. 
Interestingly, nicotinamide also is a vital cellular protectant during oxidative stress and cell injury. Administration of nicotinamide 
during periods of anoxia, oxygen-glucose deprivation or free radical exposure can not only block early cellular apoptotic programs,   
but also limit inflammatory cell activation. When one translates this work to animal studies, nicotinamide can improve cognitive 
function, reduce edema following cortical trauma, prevent spinal cord injury and limit disability in models of neurodegeneration and 
demyelinating disorders.
Yet a paradox ensues upon further consideration of nicotinamide and the pathways controlled by this agent. It appears that a   
reduction in nicotinamide levels is required to support cellular longevity and increased lifespan. For example, physiological concen-
trations of nicotinamide can block the activity of the sirtuin Sirt1, a NAD+-dependent deacetylase associated with increased cellular 
lifespan. In some scenarios, inhibition of sirtuin (Sirt1) activity can be detrimental to cell survival during oxidative stress. As a result, 
nicotinamide can function as a physiological regulator of sirtuins and supplementation of nicotinamide may at times promote cellular 
dysfunction or death rather than enhanced cellular survival. 
These observations for the agent nicotinamide bring to light the complexity of biological systems and the need for complete under-
standing of competing pathways. In this issue of Oxidative Medicine and Cellular Longevity, we have selected several insightful papers 
that provide critical assessment of intrinsic biological pathways during oxidative stress and their ultimate relationship to clinical disease. 
To begin this process with an excellent overview, Elahi et al. discuss in their paper the varied sources within a cell that can generate reac-
tive oxygen species, how these reactive species can regulate physiological function in the body, and the pathways that can lead to clinical 
disorders, such as hypertension, atherosclerosis, and cardiac ischemia. Pandey and Rizvi next take us to the world of plant polyphenols 
and outline the chemical structure and function of these agents, the bioavailability of these agents, and the application of polyphenols 
to human disease in relation to cancer, diabetes, cardiac disorders, and age-related disorders. In their paper, Maiese et al. focus upon 
cognitive loss and Alzheimer’s disease to elucidate novel treatment strategies with cytokines, such as erythropoietin, and the unique 
application of forkhead transcription factors. Although these entities can provide new directions for treatment and also are attractive as 
diagnostic biomarkers, the authors caution on the possible and sometimes unexpected detrimental effects that can ensue and express 
the necessity for further studies to fully comprehend the cellular pathways controlled by erythropoietin and forkhead transcription 
factors.
Our research papers in this issue of Oxidative Medicine and Cellular Longevity follow this premise for uncovering the specific mecha-
nisms responsible for the biological activity of a specific agent. In the paper by Tripathi and Chandra that examines the role of plant 
extracts to treat metabolic disorders, the authors show that the plant extracts of Momordica charantia and Trigonella foenum-graecum 
have the ability to modulate anti-oxidant pathways as well as control elevated glucose levels in a rat model of diabetes, suggesting a possi-
ble role for these derivatives in clinical disease. In a remarkable study also linked to cellular metabolism, Baregamian et al. delve into the 
pathways that control cellular energy function and mitochondrial autophagy to show that tumor necrosis factor-α and apoptosis signal 
regulating kinase 1 are primary targets for the control of reactive oxygen species release that lead to cell injury during neonatal necrotiz-
ing enterocolitis. Our next four studies highlight additional molecular and signal transduction pathways that can impact the cellular 
oxidative state during metabolic disorders and nutrition. Rahman et al. investigated the role of the fat-1 transgene that is responsible 
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for differential fatty acid changes in the body. They show that fat-1 has broad effects and was associated with limiting pro-inflammatory 
cytokines, reducing oxidant stress, and promoting the SIRT1 gene that is tied to increased cell longevity. Isoni et al. provide additional 
insightful knowledge for the etiology of diabetic complications in patients to focus on therapies that can alter cAMP production.   
They examined peripheral blood mononuclear cells in patients with Type 2 diabetes and performed parallel cell culture studies to show 
that elevation of cAMP can result in cytokine interleukin-6 production and possibly leading to the pathogenesis of diabetes. Work by 
Faria et al. extends this work through the examination of intestinal organic cation transport that can significantly affect absorption 
of both endogenous and exogenous substances. In essence, they show that cellular glutathione levels can alter redox potential and 
modulate uptake of multiple agents that would in turn determine the course of many disease processes. In our last paper, Baynes and 
Murray demonstrate that although metabolic disorders such as diabetes may be dependent upon shared cellular pathways, the clinical 
progression of diabetes may not follow a similar path and progress with independent variables. Such work provides vital implications 
for the treatment of clinical disease since these authors show in an animal model of diabetes that cardiac and renal disease may proceed 
independently in diabetes and therefore require strategies that target each separately. For this issue of Oxidative Medicine and Cellular 
Longevity, our studies serve to illustrate that in regards to oxidative stress and disease progression, the “forces of nature” are always in 
play and continually require full disclosure with innovative investigations for the design of clinically successful therapies.